NMR monitoring of rheumatoid arthritis patients receiving anti-TNF-α monoclonal antibody therapy
- 78 Downloads
The aim of this study was to investigate if dynamic gadolinium-DTPA-supported magnetic resonance (MR) imaging can monitor the therapeutic effect of a fast-acting immuno-modulating drug like anti-tumour necrosis factor alpha (anti-TNF-α) monoclonal antibody (moab) in patients with rheumatoid arthritis (RA). Dynamic MR imaging was performed on 64 joints in a total of 18 patients before and after infusion with either a placebo or 1 or 10 mg/kg of anti-TNF-α moab. Additionally, treating the placebo group and reinfusing the verum group with either 3 or 10 mg/kg was monitored by quantitative nuclear magnetic resonance (NMR). Time-dependent signal intensity changes were then correlated with a total of five Paulus criteria and with ESR and C-reactive protein (CRP). No changes in either the gadolinium uptake or clinical parameters were seen after the infusion of a placebo. Therapy with 1 mg/kg anti-TNF-α moab resulted in a significant decrease in clinical disease activity, as well as in gadolinium-DTPA uptake in dynamic NMR studies. However, correlations between signal intensity changes and Paulus criteria were only demonstrated for the variable “doctor's evaluation of disease activity”. Patients given 10 mg/kg moab demonstrated a very significant improvement in all clinical manifestations of their disease, as well as a high significant reduction in gadolinium uptake (P=0.004). In addition, the latter group showed significant correlations between time-dependent signal intensity changes and five Paulus criteria: “number of swollen joints”, “number of painful joints”, “duration of morning stiffness”, “doctor's evaluation of disease activity” and “patient's evaluation of disease activity”. No differences and correlations were seen for ESR and CRP. We concluded that dynamic NMR studies are suitable to monitor inflammatory activity in RA patients under therapy with biological response modifiers such as anti-TNF-α moab.
Key wordsDynamic MRI Rheumatoid arthritis Biological response modifiers
Unable to display preview. Download preview PDF.
- 1.Buckland-Wright JC (1983) X-ray-assessment of activity in rheumatoid disease. Br J Rheumatol 22:3–10Google Scholar
- 2.Adam G, Dammer M, Bohndorf K, Christoph R, Fenke F, Gunther RW (1991) Rheumatoid arthrititis of the knee: the value of gadopentetate dimenglumine-enhanced MR imaging. AJR Am J Roentgenol (United States) Jan 1991, 156 (1) pp 125–129Google Scholar
- 5.Bollow M, Konig H, Hoffmann C, Schilling A, Wolf KJ (1993) Erste Erfahrungen mit der dynamischen Magnetresonanztomographie in der Diagnostik entzündlicher Erkrankungen der Sakoiliakalgelenke. Rofo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr 159:315–324Google Scholar
- 6.Braun J, Bollow M, Eggens U, Konig H, Distler A, Sieper J (1994) Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum (United States), 37 (7) pp 1039–1045Google Scholar
- 8.Nagele M, Kunze V, Koch W, Bruning R, Seelos K, Strohmann I, Woll B, Reiser M (1993) Rheumatoid arthritis of the wrist. Dynamic Gd-DTPA enhanced MRT. Rofo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr 158:141–146Google Scholar
- 10.Feldmann M, Brennan FM, Chu Cq et al. (1993) Does TNF-alpha have a pivotal role in the cytokine network in rheumatoid arthritis? In: Fiers W (ed) Tumor necrosis factor: molecular and cellular biology and clinical relevance. Karger, Basel, pp 144–152Google Scholar
- 13.Steinbrocker O, Traeger CH, Batterman RC (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659Google Scholar
- 14.EULAR handbook of standard methods. Scott DL; van Riel PL, van der Heijde D, Benke AS (EULAR standin' Committee for International Clinical Studies, including clinical trials) (1993) Correspondence David L Scott, Queens College Hospital Hi London SE 5-9. ESCISIT (Chairman JS Smolen)Google Scholar
- 15.Paulus HE, Egger MJ, Ward JR, William HJ, the Cooperative Systematic Studies of Rheumatic Diseases Group, (1990) Analysis of improvement in individual rheumatoid arthritis patients treated with disease modifying anti-rheumatic drugs based on the findings in patients treated with placebo. Arthritis Rheum 33:477–484PubMedGoogle Scholar
- 21.Tamai K, Yamato M, Yamaguchi T, Ohno W (1994) Dynamic magnetic resonance imaging for the evaluation, of synovitis in patients with rheumatoid arthritis. Artritis Rheum 37 (8):1151–1157Google Scholar
- 23.Lorenz H-M, Antoni Ch, Valerius Th, Repp R, Grünke M, Schwerdtner N, Nüßlein H, Woody J, Kalden J-R, Manger B (1996) In vivo blockade of TNF-alpha by i.v. infusion of chimeric, monoclonal TNF-alpha antibody in patients with rheumatoid arthritis: short-term cellular and molecular) effects. J Immunol (in press)Google Scholar